November, 24 2020, 11:00pm EDT

WASHINGTON
The Environmental Protection Agency released a draft biological evaluation today finding that glyphosate is likely to injure or kill 93% of the plants and animals protected under the Endangered Species Act.
The long-anticipated draft biological evaluation released by the agency's pesticide office found that 1,676 endangered species are likely to be harmed by glyphosate, the active ingredient in Roundup and the world's most-used pesticide.
The draft biological opinion also found that glyphosate adversely modifies critical habitat for 759 endangered species, or 96% of all species for which critical habitat has been designated.
"The hideous impacts of glyphosate on the nation's most endangered species are impossible to ignore now," said Lori Ann Burd, environmental health director at the Center for Biological Diversity. "Glyphosate use is so widespread that even the EPA's notoriously industry-friendly pesticide office had to conclude that there are hardly any endangered species that can manage to evade its toxic impacts."
Hundreds of millions of pounds of glyphosate are used each year in the United States, mostly in agriculture but also on lawns, gardens, landscaping, roadsides, schoolyards, national forests, rangelands, power lines and more.
According to the EPA, 280 million pounds of glyphosate are used just in agriculture, and glyphosate is sprayed on 298 million acres of crop land each year. Eighty-four percent of glyphosate pounds applied in agriculture are applied to soy, corn and cotton, commodity crops that are genetically engineered to tolerate being drenched with quantities of glyphosate that would normally kill a plant.
Glyphosate is also widely used in fruit and vegetable production.
"As we prepare to feast on our favorite Thanksgiving dishes, the ugly truth of how harmful industrial-scale agriculture has become in the U.S. has never been so apparent," said Burd. "If we want to stop the extinction of amazing creatures like monarch butterflies, we need the EPA to take action to stop the out-of-control spraying of deadly poisons."
The EPA has, for decades, steadfastly refused to comply with its obligation under the Endangered Species Act to assess the harms of pesticides to protected plants and animals. But it was finally forced to do this evaluation under the terms of a 2016 legal agreement with the Center.
Emails obtained in litigation brought against Monsanto/Bayer by cancer victims and their families have uncovered a disturbingly cozy relationship between the agency and the company on matters involving the glyphosate risk assessment.
In one example, when the U.S. Department of Health and Human Services announced it would be reviewing glyphosate's safety, an EPA official assured Monsanto he would work to thwart the review, saying, "If I can kill this, I should get a medal." The Health and Human Services review was delayed for three years.
Monsanto/Bayer has also enjoyed broad support from the Trump White House. A domestic policy advisor in the Trump administration stated, "We have Monsanto's back on pesticides regulation."
Earlier this year, relying on confidential industry research, the EPA reapproved glyphosate. The EPA's assessment contradicts a 2015 World Health Organization analysis of published research that determined glyphosate is a probable carcinogen.
President-elect Joe Biden has already tapped Michael McCabe, a former consultant to chemical giant DuPont, to join his Environmental Protection Agency transition board, drawing broad outrage, including from Erin Brockovich.
At the Center for Biological Diversity, we believe that the welfare of human beings is deeply linked to nature — to the existence in our world of a vast diversity of wild animals and plants. Because diversity has intrinsic value, and because its loss impoverishes society, we work to secure a future for all species, great and small, hovering on the brink of extinction. We do so through science, law and creative media, with a focus on protecting the lands, waters and climate that species need to survive.
(520) 623-5252LATEST NEWS
Warren Grills Biden Medicare Trustee Pick Over 'Shocking' Ties to Medicare Advantage Firm
"Not a single other trustee has ever received compensation from an insurance company while acting as a Medicare trustee," said Sen. Elizabeth Warren.
Sep 29, 2023
Sen. Elizabeth Warren on Thursday grilled President Joe Biden's pick to fill a vacant spot on the boards that oversee Social Security and Medicare's finances, highlighting the nominee's position at a private health insurance company that relies heavily on expensive and fraud-ridden Medicare Advantage plans.
During the Senate Finance Committee's confirmation hearing for Demetrios Kouzoukas—who previously served in former President Donald Trump's Health and Human Services Department—Warren (D-Mass.) said she has serious concerns about the nominee's conflicts of interest, pointing specifically to his role on the board of Clover Health.
Citing the company's most recent filing with the Securities and Exchange Commission, Warren noted that the firm "receives a 'substantial portion' of its total revenue from Medicare Advantage premiums."
Warren pressed Kouzoukas on how much he gets paid for his work at Clover Health and on whether he plans to leave the board if confirmed as a public trustee for the Social Security and Medicare trust funds.
After repeatedly dodging, Kouzoukas pointed to a letter he received from Warren ahead of Thursday's hearing. The letter states that Kouzoukas "received compensation of more than $100,000" from Clover in 2022.
The letter also notes that Kouzoukas owns 25,000 shares of Clover stock.
Kouzoukas would not commit to leaving the Clover board if he's confirmed by the Senate.
"If you won't step down from the Clover board, then you should withdraw your nomination."
"You know, Mr. Kouzoukas, I think you think you're gonna get away with this by just not answering the question and not having any clip that admits how much money you're taking from a private insurance company that makes its money through Medicare Advantage, at the same moment that you're trying to take a public role that will influence whether we focus on the fraud in Medicare Advantage, or whether we turn a blind eye to it," Warren said.
"Let's be clear," the senator added. "If Mr. Kouzoukas ignores the fraud, he helps Clover. If he focuses on the fraud, he hurts Clover. The conflict of interest here is so big and so pervasive that there is no action that Mr. Kouzoukas can take that doesn't either help or hurt Clover, the company that pays him $100,000 a year to sit on its board and watch out for the company."
The Social Security and Medicare trust funds are typically overseen by a bipartisan pair of public trustees, but the positions have been vacant for nearly a decade. Biden nominated Kouzoukas earlier this year and Tricia Neuman, senior vice president of the health policy research organization KFF, last year.
Warren said during Thursday's hearing that "the position of public trustee was created in the 1980s to give the public a voice in the Board of Trustees' solvency projections for Medicare and Social Security."
"A big factor influencing Medicare solvency today is the growth of Medicare Advantage—a program that allows for-profit insurance companies to sell Medicare coverage that experts say is on target this year to overcharge the government by $75 billion," said Warren. "In other words, Medicare Advantage has a lot to do with threatening the solvency of Medicare."
The Massachusetts senator called Kouzoukas' financial conflict "shocking" and "deeply unethical."
"Not a single other trustee has ever received compensation from an insurance company while acting as a Medicare trustee," said Warren. "If you won't step down from the Clover board, then you should withdraw your nomination. And if you do not withdraw, given the clear conflicts posed by your board service, I will strongly oppose your nomination and I will encourage every other senator in this body to do so as well."
Social Security Works, a progressive advocacy group, expressed agreement with Warren in a social media post on Thursday.
"Senator Warren is absolutely right," the group wrote. "Demetrios Kouzoukas is on the board of Clover Health, a for-profit Medicare (Dis)Advantage corporation. In 2022, he received $100,000 from them. This is a MASSIVE conflict of interest. Kouzoukas has no business overseeing Medicare."
Keep ReadingShow Less
Sen. Dianne Feinstein Dies at 90
California's longest-serving senator suffered a string of health crises in recent months, sparking concerns about her fitness for office and calls for her resignation.
Sep 29, 2023
Democratic U.S. Sen. Dianne Feinstein, California's longest-serving senator, has died at 90.
In recent months, Feinstein faced calls from fellow Democrats to step aside as she suffered a string of health crises that forced her to miss dozens of votes and compromised her party's ability to advance judicial nominees.
As the Associated Pressreported, "One of Feinstein's most significant legislative accomplishments was early in her career, when the Senate approved her amendment to ban manufacturing and sales of certain types of assault weapons as part of a crime bill that President Bill Clinton signed into law in 1994."
The ban expired in 2004, and a Feinstein-led attempt to renew it in the wake of the Sandy Hook massacre was unsuccessful.
California Gov. Gavin Newsom said earlier this month that he would make an "interim appointment" to fill Feinstein's seat in the case of a vacancy.
Three prominent Democrats—Reps. Barbara Lee, Katie Porter, and Adam Schiff—are running for the seat in 2024. Newsom said he would not appoint any of them on an interim basis.
In a statement following news of Feinstein's death, Newsom said she "was many things—a powerful, trailblazing U.S. senator; an early voice for gun control; a leader in times of tragedy and chaos."
"But to me," he added, "she was a dear friend, a lifelong mentor, and a role model not only for me, but to my wife and daughters for what a powerful, effective leader looks like."
Keep ReadingShow Less
Dems Slam GOP for Trying to Force 'Anti-Immigrant Agenda' Into Government Funding Bill
"House Republicans cannot move their extreme, cruel, unworkable anti-immigrant agenda through the regular legislative process, so they're trying to make an end-run around Congress and hold the American people hostage to force it into law."
Sep 29, 2023
The Democratic chairs of leading congressional caucuses said late Thursday that they oppose any last-minute effort to cram immigration policy changes into government funding legislation as House and Senate Republicans consider doing just that, with a shutdown less than 48 hours away.
"It is not appropriate to establish new immigration and border policy in a bill to keep the government funded," the chairs of the Congressional Progressive Caucus, Congressional Hispanic Caucus, Congressional Asian Pacific American Caucus, and Congressional Black Caucus said in a joint statement.
"House Republicans cannot move their extreme, cruel, unworkable anti-immigrant agenda through the regular legislative process, so they're trying to make an end-run around Congress and hold the American people hostage to force it into law," they continued. "Even Minority Leader Senator McConnell has said, 'Shutting down the government isn't an effective way to make a point.' We couldn't agree more."
The Democrats' statement came in the wake of news that members of the House and Senate—with the reported backing of some Democrats in the upper chamber—are discussing the possible addition of immigration and border measures to a short-term government funding bill in a bid to win the votes of intransigent House Republicans.
Earlier this week, as the chaos-ridden House failed to make progress, the Senate advanced a legislative vehicle for a continuing resolution that would keep the government through November 17—an attempt to buy time for both chambers to approve full-year funding measures.
Citing two unnamed Republican aides, The Washington Postreported that "by Thursday evening, Senate Republicans were considering an amendment to the continuing resolution that would include $6 billion in funding for border security but no new immigration policy."
According to the Post, Sens. Chris Murphy (D-Conn.), James Lankford (R-Okla.), Susan Collins (R-Maine), Thom Tillis (R-N.C.), and Kyrsten Sinema (I-Ariz.) "appeared to be involved in the talks."
On Friday, House Speaker Kevin McCarthy (R-Calif.)—who is facing a potential removal plot by far-right House Republicans—is expected to put on the floor a Republican stopgap funding measure that includes major federal spending cuts and border policies.
The Wall Street Journalreported late Thursday that the GOP package includes changes that "House lawmakers passed earlier this year in a broader bill that orders construction to resume on the Trump administration's border wall." That bill was dead on arrival in the Senate.
"The border measures, which have broad backing in the conference, would also make it harder for people to remain in the U.S. under the protection of asylum rules," the Journal noted.
House Republicans' latest effort to move ahead with a short-term funding package will come after they passed several appropriations bills Thursday night, including measures to fund the Pentagon and State Department.
But the House voted down the GOP-authored agriculture appropriations bill, which included steep cuts to food aid for low-income families and a rollback of abortion pill access.
Rep. Rosa DeLauro (D-Conn.), the top Democrat on the House Appropriations Committee, said in a statement that lawmakers "should have spent this week working together to prevent the government from shutting down."
"Instead, we spent it watching House Republicans in chaos, loading up their 2024 funding bills with deeper cuts and dangerous policies that harm the economy and raise the cost of living for American families," said DeLauro. "Another day of Republican dysfunction, two days until they shut the government down."
Keep ReadingShow Less
Most Popular
Independent, nonprofit journalism needs your help.
Please Pitch In
Today!
Today!